25 May 2013
Keywords: profit, doubles, actelion, costs, swiss, drugmaker, full-year
Article | 02 March 2009
Swiss drugmaker Actelion's profit for full-year 2008 more than doubled in comparison to its 2007 result, which was reduced by charges.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.